Loading...
| A07453 | Pages: 220 | May 2021 | 3501 Views | | |
| Author(s) : Sushant Terdale, Sagar Mukhekar , Onkar Sumant | Tables: 112 | Charts: 65 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Infection Control Market
Request Now !The global infection control market size was valued at $32,613.75 million in 2020, and is projected to reach $38,616.77 million by 2028, registering a CAGR of 3.0% from 2021 to 2028.
Protective barriers segment is expected to witness a incline owing to increase in usage of medical nonwoven products and gloves during COVID-19 pandemic.
Infections are mainly caused by microorganisms such as virus, bacteria, and fungi or parasites. Infections can be of different types such as stomach and intestinal infections, lung & respiratory infections, eye infections, ear infections, hospital acquired infections (HAIs), skin infections, and sexually transmitted infections. These infections can be caused by the cross infection from surface and skin of patient, equipment, and healthcare staff. Different types of products and services available to control infections include sterilization, cleaning & disinfection products, protective barriers, and endoscope reprocessing products.
Get more information on this report : Request Sample Pages
Increase in incidence of hospital-acquired infections, rise in number of surgical procedures that require high intensity infection prevention & control, surge in number of government awareness program to ensure high degree infection prevention, rise in geriatric population, and surge in cases of chronic diseases such as diabetes, obesity, cancer, heart and respiratory disorders are the major factors that are expected to drive the growth of the market. In addition, rise in need for sterilization and disinfection in hospitals & clinics, technological advancements in sterilization & disinfection equipment, surge in outsourcing of sterilization services among hospitals, pharmaceutical & medical device companies, increase in production of medical nonwovens and single-use products due to surge in cases of COVID-19 are expected to drive the growth of the infection control market. However, adverse effects of chemical disinfectants and concerns regarding the safety of reprocessed instruments are expected to restrain the growth of the infection control market. Conversely, rise in adoption of single use medical nonwovens and devices is expected to offer lucrative opportunities during the forecast period.
The World Health Organization (WHO) on January 30, 2020 declared COVID-19 outbreak a public health emergency of international concern. COVID-19 has affected around 210 countries across the globe. The infection control product manufacturers are expanding their production capacity to manufacture medical nonwoven and gloves products in response to the COVID-19 pandemic. Rise in the number of COVID-19 cases and surge in need for healthcare workers are expected to drive the demand for protective barrier products and disposable hospital supplies. Thus, COVID-19 infection uplifted growth and opportunities for manufacturers of infection control products during the forecast period.
The infection control market is segmented into product & service, end user, and region. On the basis of product & service, the market is categorized into sterilization, cleaning & disinfection products, protective barriers, and endoscope reprocessing products. By sterilization, the market is divided into sterilization product, contract sterilization services, sterilization consumables and accessories. The sterilization product segment is further classified into heat sterilization equipment, low temperature sterilization equipment, radiation sterilization equipment, and other sterilization equipment. The contract sterilization services segment is further divided into ethylene oxide sterilization, e-beam sterilization, gamma sterilization, and others. The sterilization consumables and accessories segment is further classified into sterilization indicators and packaging accessories. By cleaning & disinfection products, the market is divided into disinfectants, disinfectors equipment, and others. The disinfectants segment is further divided into wipes, liquids, and sprays. By protective barriers, the market is categorized into medical nonwoven and gloves. The medical nonwoven segment is further divided into surgical gowns, face masks, coveralls, and others. By end user, the market is categorized into hospitals & clinics, pharmaceutical & medical device companies, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
On the basis of product & service, the protective barrier segment is the major revenue contributor, and is projected to grow significantly during the forecast period. Increase in public awareness toward personal hygiene, rise in number of surgeries, rise in adoption of medical nonwovens, such as face masks, surgical drapes, and gowns, due to the surge in COVID-19 cases, and increase in production of medical nonwoven products and gloves are the major factors that drive the growth of the infection control market.
Get more information on this report : Request Sample Pages
By end user, the hospitals & clinics segment is the major shareholder in the infection control market, owing to rise in volume of surgical procedures performed in hospitals, surge in prevalence of hospital-acquired infections (HAIs), increase in number of hospitals & clinics, and surge in geriatric population coupled with surge in cases of chronic diseases.
Get more information on this report : Request Sample Pages
Asia-Pacific presents lucrative opportunities for key players operating in the infection control market, owing to increase in incidences of hospital-acquired infections in emerging economies, rise in adoption of sterilization and disinfection equipment, development of the R&D sector, rise in healthcare reforms, and technological advancements in medical device manufacturing, Moreover, rise in demand for medical nonwoven products, surge in funding from government and non-government sectors to create awareness about infection prevention & control, and presence of high population base contributes toward the growth of the market. Moreover, surge in focus of leading manufacturers on expanding their geographical presence in emerging Asia-Pacific countries to capture high market share is expected to drive the growth of the infection control market in the region.
Get more information on this report : Request Sample Pages
The key players profiled in this report include 3M Company, Belimed AG, Ecolab Inc, Fortive (Advanced Sterilization Products), Getinge AB, Matachana Group, Miele Group, MMM Group, Sotera Health Llc, and Steris Plc (Cantel Medical Corporation).
Key Benefits For Stakeholders
Key Market Segments
Key Market Players
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key Benefits for Stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Rise in incidence of hospital-acquired infections (HAIs)
3.5.1.2.Upsurge in likelihood of epidemic or pandemic outbreaks
3.5.1.3.Increase in geriatric population and rise in incidence of chronic diseases
3.5.1.4.Rise in use of E-beam sterilization
3.5.2.Restraint
3.5.2.1.Adverse effects of chemical disinfectants
3.5.3.Opportunities
3.5.3.1.Growth opportunities in emerging markets
3.5.4.Impact analysis
3.6.Covid-19 Impact analysis on infection control market
CHAPTER 4:INFECTION CONTROL MARKET, BY PRODUCT & SERVICE
4.1.Overview
4.1.1.Market size and forecast
4.2.Sterilization
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.2.4.Market size and forecast, by type
4.2.4.1.Sterilization product
4.2.4.1.1.Market size and forecast
4.2.4.1.2.Market size and forecast, by type
4.2.4.1.2.1.Heat sterilization equipment
4.2.4.1.2.1.1.Market size and forecast
4.2.4.1.2.2.Low temperature sterilization equipment
4.2.4.1.2.2.1.Market size and forecast
4.2.4.1.2.3.Radiation sterilization equipment
4.2.4.1.2.3.1.Market size and forecast
4.2.4.1.2.4.Other sterilization equipment
4.2.4.1.2.4.1.Market size and forecast
4.2.4.2.Contract sterilization services
4.2.4.2.1.Market size and forecast
4.2.4.2.2.Market size and forecast, by type
4.2.4.2.2.1.Ethylene oxide sterilization
4.2.4.2.2.1.1.Market size and forecast
4.2.4.2.2.2.E-beam sterilization
4.2.4.2.2.2.1.Market size and forecast
4.2.4.2.2.3.Gamma sterilization
4.2.4.2.2.3.1.Market size and forecast
4.2.4.2.2.4.Others
4.2.4.2.2.4.1.Market size and forecast
4.2.4.3.Sterilization consumables and accessories
4.2.4.3.1.Market size and forecast
4.2.4.3.2.Market size and forecast, by type
4.2.4.3.2.1.Sterilization indicators
4.2.4.3.2.1.1.Market size and forecast
4.2.4.3.2.2.Packaging accessories
4.2.4.3.2.2.1.Market size and forecast
4.3.Cleaning & Disinfection Products
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.3.4.Market size and forecast, by type
4.3.4.1.Disinfectants
4.3.4.1.1.Market size and forecast
4.3.4.1.2.Market size and forecast, by type
4.3.4.1.2.1.Wipes
4.3.4.1.2.1.1.Market size and forecast
4.3.4.1.2.2.Liquids
4.3.4.1.2.2.1.Market size and forecast
4.3.4.1.2.3.Sprays
4.3.4.1.2.3.1.Market size and forecast
4.3.4.2.Disinfectors equipment
4.3.4.2.1.Market size and forecast
4.3.4.3.Others
4.3.4.3.1.Market size and forecast
4.4.Protective Barriers
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
4.4.4.Market size and forecast, by type
4.4.4.1.Medical Nonwoven
4.4.4.1.1.Market size and forecast
4.4.4.1.2.Market size and forecast, by type
4.4.4.1.2.1.Surgical gowns
4.4.4.1.2.1.1.Market size and forecast
4.4.4.1.2.2.Face masks
4.4.4.1.2.2.1.Market size and forecast
4.4.4.1.2.3.Coveralls
4.4.4.1.2.3.1.Market size and forecast
4.4.4.1.2.4.Others
4.4.4.1.2.4.1.Market size and forecast
4.4.4.2.Gloves
4.4.4.2.1.Market size and forecast
4.5.Endoscope reprocessing products
4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market analysis, by country
CHAPTER 5:INFECTION CONTROL MARKET, BY END USER
5.1.Overview
5.1.1.Market size and forecast
5.2.Hospitals & clinics
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Pharmaceutical & medical device companies
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.4.Others
5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country
CHAPTER 6:INFECTION CONTROL MARKET, BY REGION
6.1.Overview
6.1.1.Market size and forecast
6.2.North America
6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by country
6.2.2.1.U.S.
6.2.2.1.1.U.S. infection control market, by product & service
6.2.2.1.2.U.S. infection control market, by end user
6.2.2.2.Canada
6.2.2.2.1.Canada infection control market, by product & service
6.2.2.2.2.Canada infection control market, by end user
6.2.2.3.Mexico
6.2.2.3.1.Mexico infection control market, by product & service
6.2.2.3.2.Mexico infection control market, by end user
6.2.3.North America market size and forecast, by product & service
6.2.4.North America market size and forecast, by end user
6.3.Europe
6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by country
6.3.2.1.Germany
6.3.2.1.1.Germany infection control market, by product & service
6.3.2.1.2.Germany infection control market, by end user
6.3.2.2.France
6.3.2.2.1.France infection control market, by product & service
6.3.2.2.2.France infection control market, by end user
6.3.2.3.UK
6.3.2.3.1.UK infection control market, by product & service
6.3.2.3.2.UK infection control market, by end user
6.3.2.4.Italy
6.3.2.4.1.Italy infection control market, by product & service
6.3.2.4.2.Italy infection control market, by end user
6.3.2.5.Spain
6.3.2.5.1.Spain infection control market, by product & service
6.3.2.5.2.Spain infection control market, by end user
6.3.2.6.Rest of Europe
6.3.2.6.1.Rest of Europe infection control market, by product & service
6.3.2.6.2.Rest of Europe infection control market, by end user
6.3.3.Europe market size and forecast, by product & service
6.3.4.Europe market size and forecast, by end user
6.4.Asia-Pacific
6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by country
6.4.2.1.Japan
6.4.2.1.1.Japan infection control market, by product & service
6.4.2.1.2.Japan infection control market, by end user
6.4.2.2.China
6.4.2.2.1.China infection control market, by product & service
6.4.2.2.2.China infection control market, by end user
6.4.2.3.Australia
6.4.2.3.1.Australia infection control market, by product & service
6.4.2.3.2.Australia infection control market, by end user
6.4.2.4.India
6.4.2.4.1.India infection control market, by product & service
6.4.2.4.2.India infection control market, by end user
6.4.2.5.South Korea
6.4.2.5.1.South Korea infection control market, by product & service
6.4.2.5.2.South Korea infection control market, by end user
6.4.2.6.Rest of Asia-Pacific
6.4.2.6.1.Rest of Asia-Pacific infection control market, by product & service
6.4.2.6.2.Rest of Asia-Pacific infection control market, by end user
6.4.3.Asia-Pacific market size and forecast, by product & service
6.4.4.Asia-Pacific market size and forecast, by end user
6.5.LAMEA
6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast, by country
6.5.2.1.Brazil
6.5.2.1.1.Brazil infection control market, by product & service
6.5.2.1.2.Brazil infection control market, by end user
6.5.2.2.Saudi Arabia
6.5.2.2.1.Saudi Arabia infection control market, by product & service
6.5.2.2.2.Saudi Arabia infection control market, by end user
6.5.2.3.South Africa
6.5.2.3.1.South Africa infection control market, by product & service
6.5.2.3.2.South Africa infection control market, by end user
6.5.2.4.Rest of LAMEA
6.5.2.4.1.Rest of LAMEA infection control market, by product & service
6.5.2.4.2.Rest of LAMEA infection control market, by end user
6.5.3.LAMEA market size and forecast, by product & service
6.5.4.LAMEA market size and forecast, by end user
CHAPTER 7:COMPANY PROFILES
7.1.3M COMPANY
7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance
7.1.6.Key strategic moves and developments
7.2.BELIMED AG.
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Business performance
7.3.ECOLAB INC.
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance
7.3.6.Key strategic moves and developments
7.4.FORTIVE CORPORATION (ADVANCED STERILIZATION PRODUCTS).
7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance
7.4.6.Key strategic moves and developments
7.5.GENITGE AB.
7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.5.5.Business performance
7.5.6.Key strategic moves and developments
7.6.MATACHANA GROUP.
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Key strategic moves and developments
7.7.MIELE GROUP. (STEELCO)
7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.8.MMM GROUP
7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio
7.9.SOTERA HEALTH INC.
7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance
7.9.6.Key strategic moves and developments
7.10.STERIS PLC (CANTEL MEDICAL CORPORATION).
7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Business performance
7.10.6.Key strategic moves and developments
LIST OF TABLES
TABLE 01.INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
TABLE 02.INFECTION CONTROL MARKET FOR STERILIZATION, BY REGION, 2020-2028 ($MILLION)
TABLE 03.STERILIZATION INFECTION CONTROL MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 04.STERILIZATION PRODUCT MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 05.CONTRACT STERILIZATION SERVICES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 06.STERILIZATION CONSUMABLES AND ACCESSORIES MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 07.INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY REGION, 2020-2028 ($MILLION)
TABLE 08.CLEANING & DISINFECTION PRODUCTS INFECTION CONTROL MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 09.DISINFECTANTS MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 10.INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY REGION, 2020-2028 ($MILLION)
TABLE 11.INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY TYPE, 2020–2028 ($MILLION)
TABLE 12.MEDICAL NONWOVEN MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 13.INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY REGION, 2020-2028 ($MILLION)
TABLE 14.INFECTION CONTROL MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 15.INFECTION CONTROL MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020-2028 ($MILLION)
TABLE 16.INFECTION CONTROL MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE COMPANIES, BY REGION, 2020-2028 ($MILLION)
TABLE 17.INFECTION CONTROL MARKET FOR OTHERS, BY REGION, 2020-2028 ($MILLION)
TABLE 18.INFECTION CONTROL MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 19.NORTH AMERICA INFECTION CONTROL MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 20.U.S. INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 21.U.S. INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 22.CANADA INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 23.CANADA INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 24.MEXICO INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 25.MEXICO INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 26.NORTH AMERICA INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 27.NORTH AMERICA INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 28.EUROPE INFECTION CONTROL MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 29.GERMANY INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 30.GERMANY INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 31.FRANCE INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 32.FRANCE INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 33.UK INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 34.UK INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 35.ITALY INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 36.ITALY INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 37.SPAIN INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 38.SPAIN INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 39.REST OF EUROPE INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 40.REST OF EUROPE INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 41.EUROPE INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 42.EUROPE INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 43.ASIA-PACIFIC INFECTION CONTROL MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 44.JAPAN INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 45.JAPAN INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 46.CHINA INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 47.CHINA INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 48.AUSTRALIA INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 49.AUSTRALIA INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 50.INDIA INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 51.INDIA INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 52.SOUTH KOREA INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 53.SOUTH KOREA INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 54.REST OF ASIA-PACIFIC INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 55.REST OF ASIA-PACIFIC INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 56.ASIA-PACIFIC INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 57.ASIA-PACIFIC INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 58.LAMEA INFECTION CONTROL MARKET, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 59.BRAZIL INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 60.BRAZIL INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 61.SAUDI ARABIA INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 62.SAUDI ARABIA INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 63.SOUTH AFRICA INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 64.SOUTH AFRICA INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 65.REST OF LAMEA INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 66.REST OF LAMEA INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 67.LAMEA INFECTION CONTROL MARKET, BY PRODUCT & SERVICE, 2020–2028 ($MILLION)
TABLE 68.LAMEA INFECTION CONTROL MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 69.3M: COMPANY SNAPSHOT
TABLE 70.3M: OPERATING SEGMENTS
TABLE 71.3M: PRODUCT PORTFOLIO
TABLE 72.BELIMED: COMPANY SNAPSHOT
TABLE 73.BELIMED: OPERATING SEGMENTS
TABLE 74.BELIMED: PRODUCT PORTFOLIO
TABLE 75.ECOLAB: COMPANY SNAPSHOT
TABLE 76.ECOLAB: OPERATING SEGMENTS
TABLE 77.ECOLAB: PRODUCT PORTFOLIO
TABLE 78.FORTIVE: COMPANY SNAPSHOT
TABLE 79.FORTIVE: OPERATING SEGMENTS
TABLE 80.FORTIVE: PRODUCT PORTFOLIO
TABLE 81.GENITGE: COMPANY SNAPSHOT
TABLE 82.GETINGE: OPERATING SEGMENTS
TABLE 83.GETINGE: PRODUCT PORTFOLIO
TABLE 84.MATACHNA: COMPANY SNAPSHOT
TABLE 85.MATACHANA: OPERATING SEGMENTS
TABLE 86.MATACHANA: PRODUCT PORTFOLIO
TABLE 87.MIELE: COMPANY SNAPSHOT
TABLE 88.MIELE: OPERATING SEGMENTS
TABLE 89.MIELE: PRODUCT PORTFOLIO
TABLE 90.MMM COMPANY SNAPSHOT
TABLE 91.MMM: OPERATING SEGMENTS
TABLE 92.MMM: PRODUCT PORTFOLIO
TABLE 93.SOTERA HEALTH: COMPANY SNAPSHOT
TABLE 94.SOTERA HEALTH: OPERATING SEGMENTS
TABLE 95.SOTERA HEALTH: PRODUCT PORTFOLIO
TABLE 96.STERIS: COMPANY SNAPSHOT
TABLE 97.STERIS: OPERATING SEGMENTS
TABLE 98.STERIS: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.INFECTION CONTROL MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018-2020
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2020
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018-2020
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.HIGH THREAT OF SUBSTITUTES
FIGURE 09.HIGH THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.COMPARATIVE ANALYSIS OF INFECTION CONTROL MARKET FOR STERILIZATION, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 14.STERILIZATION PRODUCT MARKET, 2020–2028 ($MILLION)
FIGURE 15.HEAT STERILIZATION EQUIPMENT MARKET, 2020–2028 ($MILLION)
FIGURE 16.LOW TEMPERATURE STERILIZATION EQUIPMENT MARKET, 2020–2028 ($MILLION)
FIGURE 17.RADIATION STERILIZATION EQUIPMENT MARKET, 2020–2028 ($MILLION)
FIGURE 18.OTHER STERILIZATION EQUIPMENT MARKET, 2020–2028 ($MILLION)
FIGURE 19.CONTRACT STERILIZATION SERVICES MARKET, 2020–2028 ($MILLION)
FIGURE 20.ETHYLENE OXIDE STERILIZATION MARKET, 2020–2028 ($MILLION)
FIGURE 21.E-BEAM STERILIZATION MARKET, 2020–2028 ($MILLION)
FIGURE 22.GAMMA STERILIZATION MARKET, 2020–2028 ($MILLION)
FIGURE 23.OTHERS STERILIZATION MARKET, 2020–2028 ($MILLION)
FIGURE 24.STERILIZATION CONSUMABLES AND ACCESSORIES MARKET, 2020–2028 ($MILLION)
FIGURE 25.STERILIZATION INDICATORS MARKET, 2020–2028 ($MILLION)
FIGURE 26.PACKAGING ACCESSORIES MARKET, 2020–2028 ($MILLION)
FIGURE 27.COMPARATIVE ANALYSIS OF INFECTION CONTROL MARKET FOR CLEANING & DISINFECTION PRODUCTS, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 28.DISINFECTANTS MARKET, 2020–2028 ($MILLION)
FIGURE 29.WIPES MARKET, 2020–2028 ($MILLION)
FIGURE 30.LIQUIDS MARKET, 2020–2028 ($MILLION)
FIGURE 31.SPRAYS MARKET, 2020–2028 ($MILLION)
FIGURE 32.DISINFECTORS EQUIPMENT MARKET, 2020–2028 ($MILLION)
FIGURE 33.OTHERS CLEANING & DISINFECTION PRODUCTS MARKET, 2020–2028 ($MILLION)
FIGURE 34.COMPARATIVE ANALYSIS OF INFECTION CONTROL MARKET FOR PROTECTIVE BARRIERS, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 35.MEDICAL NONWOVEN MARKET, 2020–2028 ($MILLION)
FIGURE 36.SURGICAL GOWNS MARKET, 2020–2028 ($MILLION)
FIGURE 37.FACE MASKS MARKET, 2020–2028 ($MILLION)
FIGURE 38.COVERALLS MARKET, 2020–2028 ($MILLION)
FIGURE 39.OTHERS MEDICAL NONWOVEN MARKET, 2020–2028 ($MILLION)
FIGURE 40.GLOVES MARKET, 2020–2028 ($MILLION)
FIGURE 41.COMPARATIVE ANALYSIS OF INFECTION CONTROL MARKET FOR ENDOSCOPE REPROCESSING PRODUCTS, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 42.COMPARATIVE ANALYSIS OF INFECTION CONTROL MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 43.COMPARATIVE ANALYSIS OF INFECTION CONTROL MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE COMPANIES, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 44.COMPARATIVE ANALYSIS OF INFECTION CONTROL MARKET FOR OTHERS, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 45.3M:NET SALES,2018-2020 ($MILLION)
FIGURE 46.3M: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 47.3M: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 48.BELIMED:NET SALES, 2018-2020 ($MILLION)
FIGURE 49.BELIMED: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 50.BELIMED: REVENUE SHARE BY REGION 2020 (%)
FIGURE 51.ECOLAB: NET SALES, 2018-2020 ($MILLION)
FIGURE 52.ECOLAB: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 53.ECOLAB: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 54.FORTIVE: NET SALES, 2018-2020 ($MILLION)
FIGURE 55.FORTIVE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 56.FORTIVE: REVENUE SHARE BY REGION 2020 (%)
FIGURE 57.GETINGE: NET SALES, 2018-2020 ($MILLION)
FIGURE 58.GETINGE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 59.GENTIGE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 60.SOTERA HEALTH: NET SALES, 2018–2020 ($MILLION)
FIGURE 61.SOTERA HEALTH: REVENUE SHARE BY SEGMENTS, 2020(%)
FIGURE 62.SOTERA HEALTH: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 63.STERIS: NET SALES, 2018–2020 ($MILLION)
FIGURE 64.STERIS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 65.STERIS: REVENUE SHARE BY REGION, 2020 (%)
Infectious diseases and disorders are mainly caused by pathogenic microorganisms, such as viruses, and parasites or fungi bacteria. These diseases can be spread, indirectly or directly, from infected or non-sterilized medical or surgical equipment used to treat a person, or from presence in the infected environment of any healthcare facility. Infection control is the most preferred preventable measure, to prevent these infections.
The factors such as increase in incidences of hospital-acquired infections, surge in number of surgical procedures, growing medical device reprocessing industry, and rise in incidence of chronic diseases associated with surge in geriatric population are expected to drive the growth of the infection control market. Moreover, adoption of new technologies with advancements in the technology of infection control devices further boosts the growth of the market. However, adverse effects of chemical disinfectants and concerns regarding the safety of reprocessed instruments are expected to restrain the growth of the infection control market.
A. The total market value of Infection Control market is $ 32,614 million in 2020.
A. The forcast period for Infection Control market is 2021 to 2028
A. The market value of Infection Control market in 2021 is $31,486.3 million.
A. The base year is 2020 in Infection Control market
A. Top companies such as Steris Plc (Cantel Medical Corporation), Getinge AB, 3M Company, Fortive (Advanced Sterilization Products), Sotera Health Llc, Belimed AG, and Ecolab Inc held a high market position in 2020. These key players held a high market postion owing to the strong geographical foothold in different regions.
A. Protective barriers segment is the most influencing segment owing to rise in adoption of medical nonwovens, such as face masks, surgical drapes, and gowns, due to the surge in COVID-19 cases, surge in number of surgeries, and increase in public awareness towards personal hygiene.
A. Surge in number of surgical procedures, rise in incidence of hospital acquired infection, technological advancements in sterilization and disinfection technologies, surge in geriatric population, increase in government and non-government initiatives relating to spreading awareness concerning need for disinfection and need of proper hygiene drive the growth of the market.
A. Asia-Pacific has the highest growth rate in the market which is growing due to the increase in awareness related to personal hygiene, rise in number of surgical procedures, availability of trained medical professionals, and supportive reimbursement policies in the healthcare system.
A. Infectious diseases are caused by microorganisms such as viruses, bacteria, parasites, or fungi. Infection can be classified into various types, which include hospital acquired infections (HAIs), ear infections, eye infections, lung & respiratory infections, skin infections, common childhood infections, sexually transmitted infections, and stomach & intestinal infections
A. Infection control is concerned with preventing and controlling health care associated infections and sterilization technique is a major component of invasive surgical procedure
Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
